Literature DB >> 27796523

Adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire for use in Serbia.

Mirjana Zlatkovic-Svenda1,2, Matthew Rouse3, Marija Radak-Perovic4,5, Roksanda Stojanovic4,5, Nada Vujasinovic-Stupar4,5, Biljana Lazovic-Popovic5,6, Jeanette Wilburn3, Stephen P McKenna7.   

Abstract

Rheumatoid arthritis (RA) is one of the most prevalent inflammatory rheumatic diseases. As it is a chronic and a lifelong destructive disease, the aim of the treatment is to reduce disability and improve quality of life. The Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire is a patient-reported outcome measure, specific to RA. To adapt and validate the RAQoL for use in Serbia, two translation panels were involved to produce the Serbian RAQoL. After successful translation, face and content validity was determined via cognitive debriefing interviews. The psychometric properties of the questionnaire were examined, including reliability and construct validity, by using the Nottingham Health Profile (NHP) as a comparator scale. The RAQoL was translated successfully and rated as applicable, relevant and comprehensive by respondents. The questionnaire had high internal consistency (alpha = 0.94 at both time points) and test-retest reliability (r = 0.92). Moderately high correlations were found between the RAQoL and physical mobility, pain and energy level sections of the NHP, providing evidence of convergent validity. The RAQoL was able to distinguish between patients grouped by perceived general health, incidence of flare-up and disease severity. The Serbian language version of the RAQoL showed strong evidence of reliability and validity and is recommended for use in clinical trials and routine general practice in RA.

Entities:  

Keywords:  Adaptation; Quality of life; Rheumatoid arthritis; Translation; Validation

Mesh:

Year:  2016        PMID: 27796523     DOI: 10.1007/s00296-016-3586-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?

Authors:  James Twiss; David M Meads; Elizabeth P Preston; Sigrid R Crawford; Stephen P McKenna
Journal:  J Invest Dermatol       Date:  2011-09-01       Impact factor: 8.551

Review 2.  The consequences of rheumatoid arthritis: quality of life measures in the individual patient.

Authors:  L Pollard; E H Choy; D L Scott
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

3.  The QLDS: a scale for the measurement of quality of life in depression.

Authors:  S M Hunt; S P McKenna
Journal:  Health Policy       Date:  1992-10       Impact factor: 2.980

4.  The Nottingham Health Profile: subjective health status and medical consultations.

Authors:  S M Hunt; S P McKenna; J McEwen; J Williams; E Papp
Journal:  Soc Sci Med A       Date:  1981-05

5.  Responsiveness of generic and disease-specific health-related quality of life instruments to venous ulcer healing.

Authors:  Andrew Jull; Varsha Parag; Natalie Walker; Anthony Rodgers
Journal:  Wound Repair Regen       Date:  2010 Jan-Feb       Impact factor: 3.617

6.  Prevalence of rheumatoid arthritis in Serbia.

Authors:  Mirjana I Zlatković-Švenda; Roksanda M Stojanović; Sandra B Šipetić-Grujičić; Francis Guillemin
Journal:  Rheumatol Int       Date:  2013-11-29       Impact factor: 2.631

7.  Rose hip herbal remedy in patients with rheumatoid arthritis - a randomised controlled trial.

Authors:  S N Willich; K Rossnagel; S Roll; A Wagner; O Mune; J Erlendson; A Kharazmi; H Sörensen; K Winther
Journal:  Phytomedicine       Date:  2009-10-08       Impact factor: 5.340

8.  Development and validation of a needs-based quality of life instrument for osteoarthritis.

Authors:  Anne-Maree Keenan; Stephen P McKenna; Lynda C Doward; Philip G Conaghan; Paul Emery; Alan Tennant
Journal:  Arthritis Rheum       Date:  2008-06-15

9.  Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.

Authors:  Victoria Bejarano; Mark Quinn; Philip G Conaghan; Richard Reece; Anne-Maree Keenan; David Walker; Andrew Gough; Michael Green; Dennis McGonagle; Ade Adebajo; Stephen Jarrett; Sheelagh Doherty; Lesley Hordon; Richard Melsom; Kristina Unnebrink; Hartmut Kupper; Paul Emery
Journal:  Arthritis Rheum       Date:  2008-10-15

10.  Responsiveness of five condition-specific and generic outcome assessment instruments for chronic pain.

Authors:  Felix Angst; Martin L Verra; Susanne Lehmann; André Aeschlimann
Journal:  BMC Med Res Methodol       Date:  2008-04-25       Impact factor: 4.615

View more
  1 in total

1.  Comparison of health-related quality of life in patients with rheumatoid arthritis during conventional or conventional plus biological therapy in Poland.

Authors:  Ewelina Bąk; Czesław Marcisz; Adriana Borodzicz; Danuta Sternal; Sylwia Krzemińska
Journal:  Patient Prefer Adherence       Date:  2019-01-24       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.